leadXpro AG, Switzerland
Michael Hennig studied Physics and Biochemistry, received the Ph.D. in structural biology at EMBL Hamburg, and the Charité, Humboldt University Berlin, Germany. It followed two years postdoc work at the Biozentrum, University of Basel, Switzerland. He is author of more than 80 scientific peer reviewed paper and, since 2011, guest professor in structural biology at the University of Basel. He worked 20 years in pharmaceutical industry at Roche, Basel, Switzerland in various positions and finally Global Head and Principle Leader of discovery technologies with responsibility for structure-based drug discovery, protein science, assay development and HTS, Roche corporate compound library, stem cell platform and analytical physical methods. In 2015, he co-founded leadXpro, a corporation dedicated to structure-based drug discovery for membrane protein targets (GPCR’s, Ion-channels, Transporter) and utilizing most advanced technologies such as the X-ray free electron laser (at PSI, SwissFEL) and cryo-electron microscopy (at University of Basel, cryo-EM).
University of Dresden, Germany
Karim Fahmy received his PhD at the University of Freiburg in membrane protein research. During his postdoc studies as a Howard Hughes Medical Institute Fellow with Prof. Tom Sakmar at Rockefeller University, New York, he performed seminal work in combining site-directed mutagenesis with infrared spectroscopy to elucidate functional mechanisms of G protein-coupled receptors. After his habilitation at the University of Freiburg he joined the Helmholtz-Zentrum Dresden-Rossendorf heading the Department of Biophysics, where his lab focuses on the design of novel membrane mimetics for structural studies of membrane proteins based on DNA-lipid assembly. Karim Fahmy is affiliated Professor at the University of Dresden. He has headed the Molecular Biophysics Section of the German Biophysical Society and is recipient of the Hans-Griesebach-Price of the University of Freiburg.
Polytechnic Institute of Santarem, Portugal
Expertise in the biological evaluation and toxicity studies of natural and synthetic compounds and food chemistry.
University of Rochester, USA
Bern University, Switzerland
Prof. Niklaus Ammann completed PhD at the age of 34 from Bern University and with postdoctoral studies in Duke University. He was the director of the Bern Botanic Garden until 2006 and he has published more than 200 peer reviewed papers in reputed journals on biodiversity, Gene Flow and Ecology of Transgenic Crops. He is the editorial board member of New Biotechnology.
National Institutes of Health, USA
Dr. Bai pioneered the native-state hydrogen exchange approach for revealing partially unfolded states of proteins. His group solved several NMR structures of the folding intermediates. Recently, his research interest has shifted to understanding the basic principles that control the dynamic folding/unfolding processes of chromatin using biophysical approaches. His group’s studies of nucleosomes by methyl-based NMR approach have resulted in structural insights into the nucleosome in complex with several important proteins including the kinetochore proteins. Currently, his group is combining cryo-EM and NMR to study the structures of nucleosomes containing native-DNA sequences and chromatosomes containing different human linker histone variants.
University of Lisbon, Portugal
Amélia Pilar Rauter has made her Habilitation at Faculty of Sciences, University of Lisbon (FCUL, 2002) and completed her PhD at Technische Universitaet Graz, Austria (1982). She is the Head of the Carbohydrate Chemistry Group - Center of Chemistry and Biochemistry (FCUL), and has been serving as Editor (RSC Carbohydrate Chemistry book series), Associated Editor (Mediterranean Journal of Chemistry), and member of journals advisory board in Organic/Carbohydrate Chemistry. She is Secretary of the European Carbohydrate Organisation and Secretary of the IUPAC Division on Organic and Biomolecular Chemistry, has published more than 130 papers and book chapters, and authored 12 patents.
University of California, USA
Dr. Holland Cheng is Professor in the Department of Molecular and Cellular Biology at University of California Davis, Davis, California, USA. His research interests includes structural biology; 3D image reconstruction; microscopy; vaccine design; virus structures; molecular medicine; genomics; proteomics and metabolomics.